Japan Approves AstraZeneca Asthma Drug, To Be Marketed With Astellas
This article was originally published in PharmAsia News
Executive Summary
Japan's drug regulator approved U.K.-based AstraZeneca's Symbicort (budesonide) for treating adult asthma
Japan's drug regulator approved U.K.-based AstraZeneca's Symbicort (budesonide) for treating adult asthma. Astellas Pharma is to market the drug in Japan. Symbicort already is a major drug for the British drug maker in Europe and the United States. The drug was approved by the health ministry for the Japanese market in inhaler form. (Click here for more) "Japan Approves AstraZeneca's Symbicort" - Mainichi Daily News (Japan) (10/17/09) |